Literature DB >> 8797530

Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.

K Hatanpää1, D R Brady, J Stoll, S I Rapoport, K Chandrasekaran.   

Abstract

We studied neuronal activity and its relation to the accumulation of neurofibrillary tangles in Alzheimer's disease (AD) neurons by in situ hybridization to cytochrome oxidase subunit III messenger RNA, a marker of mitochondrial energy metabolism. In AD midtemporal cortex, levels of cytochrome oxidase subunit III messenger RNA were decreased by 26% in neurons bearing early-stage neurofibrillary tangles as compared to tangle-free neurons (p < 0.01). However, levels of 12S ribosomal RNA, also encoded by mitochondrial DNA, and of total messenger RNA were decreased only in later stages of tangle development. Comparing tangle-free neurons of 4 AD brains to tangle-free neurons of 3 control brains, levels of cytochrome oxidase subunit III messenger RNA were found to be 25% lower (p < 0.001) in AD tangle-free neurons. Because energy metabolic needs of neurons are mainly determined by synaptic input, the observed decreases in cytochrome oxidase subunit III messenger RNA likely reflect downregulation due to impaired synaptic function in AD. Thus, a failure in synaptic transmission may precede tangle formation. A further decline in neuronal activity is seen as tangle formation progresses. However, these results can also be viewed as showing the viability and continuing activity, albeit at a lower level, of neurons in the early stages of neurofibrillary pathology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797530     DOI: 10.1002/ana.410400310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

3.  Biomarkers and evolution in Alzheimer disease.

Authors:  Stanley I Rapoport; Peter T Nelson
Journal:  Prog Neurobiol       Date:  2011-07-23       Impact factor: 11.685

4.  Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits.

Authors:  Andrew M Ward; Elizabeth C Mormino; Willem Huijbers; Aaron P Schultz; Trey Hedden; Reisa A Sperling
Journal:  Neurobiol Aging       Date:  2014-07-03       Impact factor: 4.673

5.  Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex.

Authors:  N Y Huang; M Strakhova; R T Layer; P Skolnick
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

Review 6.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

7.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

8.  A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.

Authors:  Steven G Potkin; Gus Alva; Ibrahim Gunay; Barbara Koumaras; Michael Chen; Dario Mirski
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

9.  Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Authors:  Linda Zhang; Raymond Chuen-Chung Chang; Leung-Wing Chu; Henry Ka-Fung Mak
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

10.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.